{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T15:40:17Z","timestamp":1778773217188,"version":"3.51.4"},"reference-count":85,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ajpm-online.net","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.amepre.2015.09.012","type":"journal-article","created":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T05:01:54Z","timestamp":1447822914000},"page":"S355-S363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"S4","title":["Prospects for Broadly Protective Influenza Vaccines"],"prefix":"10.1016","volume":"49","author":[{"given":"John Jay","family":"Treanor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amepre.2015.09.012_bib1","first-page":"43","article-title":"Influenza: experiments on the active immunisation of mice","volume":"18","author":"Andrewes","year":"1937","journal-title":"Br J Exp Path"},{"key":"10.1016\/j.amepre.2015.09.012_bib2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3181\/00379727-55-14477P","article-title":"Protective effect of vaccination against influenza","volume":"55","author":"Francis","year":"1944","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.amepre.2015.09.012_bib3","doi-asserted-by":"crossref","first-page":"10748","DOI":"10.1073\/pnas.162366899","article-title":"The total influenza vaccine failure of 1947 revisited: major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic","volume":"99","author":"Kilbourne","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.amepre.2015.09.012_bib4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.7326\/0003-4819-33-2-371","article-title":"Influenza A prime: a clinical study of an epidemic caused by a new strain of virus","volume":"33","author":"Kilbourne","year":"1950","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amepre.2015.09.012_bib5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1586\/erv.13.35","article-title":"Immunologic assessment of influenza vaccines and immune correlates of protection","volume":"12","author":"Reber","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.amepre.2015.09.012_bib6","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1016\/j.vaccine.2007.02.039","article-title":"Comparison of neutralising antibody assays for detection of antibody to influenza A\/H3N2 viruses: an international collaborative study","volume":"25","author":"Stephenson","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.amepre.2015.09.012_bib7","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/INF.0b013e3182367662","article-title":"Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children","volume":"30","author":"Black","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.amepre.2015.09.012_bib8","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1146\/annurev.iy.08.040190.003513","article-title":"Structural basis of immune recognition of influenza virus hemagglutinin","volume":"8","author":"Wilson","year":"1990","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.amepre.2015.09.012_bib9","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.coviro.2013.05.008","article-title":"To dream the impossible dream: universal influenza vaccination","volume":"3","author":"Yewdell","year":"2013","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.amepre.2015.09.012_bib10","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1073\/pnas.0801367105","article-title":"Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies","volume":"105","author":"Kashyap","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.amepre.2015.09.012_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1084\/jem.201013522082c","article-title":"Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection","volume":"208","author":"Wrammert","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.amepre.2015.09.012_bib12","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/science.1171491","article-title":"Antibody recognition of a highly conserved influenza virus epitope","volume":"324","author":"Ekiert","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.amepre.2015.09.012_bib13","first-page":"843","article-title":"A highly conserved neutralizing epitope on group 2 influenza","volume":"333","author":"Ekiert","year":"2011","journal-title":"A Viruses Sci"},{"key":"10.1016\/j.amepre.2015.09.012_bib14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/infdis\/jis652","article-title":"1976 and 2009 H1N1 influenza virus vaccines boost anti-hemagglutinin stalk antibodies in humans","volume":"207","author":"Miller","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.amepre.2015.09.012_bib15","doi-asserted-by":"crossref","first-page":"13260","DOI":"10.1128\/JVI.02133-14","article-title":"Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans","volume":"88","author":"Nachbagauer","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.amepre.2015.09.012_bib16","doi-asserted-by":"crossref","first-page":"e00150","DOI":"10.1128\/mBio.00150-11","article-title":"Why do influenza subtypes die out? A hypothesis","volume":"2","author":"Palese","year":"2011","journal-title":"mBio"},{"key":"10.1016\/j.amepre.2015.09.012_bib17","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.coviro.2013.07.007","article-title":"Influenza virus hemagglutinin stalk-based antibodies and vaccines","volume":"3","author":"Krammer","year":"2013","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.amepre.2015.09.012_bib18","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/cid\/cir121","article-title":"Wide prevalence of heterosubtypic broadly neutralizing human anti-influenza A antibodies","volume":"52","author":"Sui","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amepre.2015.09.012_bib19","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1128\/JVI.03509-12","article-title":"H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice","volume":"87","author":"Margine","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.amepre.2015.09.012_bib20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev-med-120611-145115","article-title":"Towards a universal influenza virus vaccine: prospects and challenges","volume":"64","author":"Pica","year":"2013","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.amepre.2015.09.012_bib21","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.amepre.2015.09.012_bib22","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1128\/JVI.03183-13","article-title":"H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge","volume":"88","author":"Krammer","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.amepre.2015.09.012_bib23","doi-asserted-by":"crossref","first-page":"e00018-10","DOI":"10.1128\/mBio.00018-10","article-title":"Influenza virus vaccine based on the conserved hemagglutinin stalk domain","volume":"1","author":"Steel","year":"2010","journal-title":"mBio"},{"key":"10.1016\/j.amepre.2015.09.012_bib24","doi-asserted-by":"crossref","first-page":"18979","DOI":"10.1073\/pnas.1013387107","article-title":"Vacccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes","volume":"107","author":"Wang","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.amepre.2015.09.012_bib25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1073\/pnas.1308701110","article-title":"Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines","volume":"111","author":"Lu","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.amepre.2015.09.012_bib26","doi-asserted-by":"crossref","first-page":"e18314","DOI":"10.1371\/journal.pone.0018314","article-title":"Protection against divergent influenza H1N1 virus by a centralized influenza hemagglutinin","volume":"6","author":"Weaver","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.amepre.2015.09.012_bib27","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/j.vaccine.2011.01.100","article-title":"A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets","volume":"29","author":"Giles","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.amepre.2015.09.012_bib28","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1128\/CVI.05533-11","article-title":"Antibody breadth and protective efficacy are increased by vaccination with computationally optimized hemagglutinin but not with polyvalent hemagglutinin-based H5N1 virus-like particle vaccines","volume":"19","author":"Giles","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.amepre.2015.09.012_bib29","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/infdis\/jis232","article-title":"A computationally optimized hemagglutinin virus-like particle vaccine elicits broadly reactive antibodies that protect nonhuman primates from H5N1 infection","volume":"205","author":"Giles","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.amepre.2015.09.012_bib30","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0042-6822(88)90640-X","article-title":"Protection against lethal influenza with neuraminidase","volume":"164","author":"Webster","year":"1988","journal-title":"Virology"},{"key":"10.1016\/j.amepre.2015.09.012_bib31","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1128\/JVI.63.11.4603-4608.1989","article-title":"Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics","volume":"63","author":"Kawaoka","year":"1989","journal-title":"J Virol"},{"key":"10.1016\/j.amepre.2015.09.012_bib32","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJM197206222862502","article-title":"Association of serum antineuraminidase antibody with resistance to influenza in man","volume":"286","author":"Murphy","year":"1972","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amepre.2015.09.012_bib33","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(73)92196-X","article-title":"Effect of neuraminidase antibody on Hong Kong influenza","volume":"7804","author":"Monto","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.amepre.2015.09.012_bib34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1128\/JCM.24.1.157-160.1986","article-title":"Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus","volume":"24","author":"Clements","year":"1986","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.amepre.2015.09.012_bib35","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0264-410X(93)90130-P","article-title":"Infection-permissive immunization with influenza virus neuraminidase prevents weight loss in infected mice","volume":"11","author":"Johansson","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.amepre.2015.09.012_bib36","doi-asserted-by":"crossref","first-page":"20748","DOI":"10.1073\/pnas.1113801108","article-title":"Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses","volume":"108","author":"Sandbulte","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.amepre.2015.09.012_bib37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0022-1759(90)90255-T","article-title":"Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substrates","volume":"135","author":"Lambre","year":"1990","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.amepre.2015.09.012_bib38","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.vaccine.2009.12.041","article-title":"A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine amont elderly subjects","volume":"28","author":"Cate","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.amepre.2015.09.012_bib39","doi-asserted-by":"crossref","first-page":"ofu115","DOI":"10.1093\/ofid\/ofu115","article-title":"Comparison of serum hemagglutinin and neuraminidase inhibition antiboides after 2010\u20132011 trivalent inactivated vaccination in healthcare personnel","author":"Laguio-Vila","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.amepre.2015.09.012_bib40","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiv195","article-title":"Antibody to influenza virus neuraminidase: an independent correlate of protection","author":"Monto","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.amepre.2015.09.012_bib41","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1128\/JVI.67.10.5721-5723.1993","article-title":"Dissociation of influenza virus hemagglutinin and neuraminidase eliminates their intravirionic antigenic competion","volume":"67","author":"Johansson","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.amepre.2015.09.012_bib42","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0264-410X(98)00413-7","article-title":"Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine","volume":"17","author":"Johansson","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.amepre.2015.09.012_bib43","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/0264-410X(95)00127-M","article-title":"Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans","volume":"13","author":"Kilbourne","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.amepre.2015.09.012_bib44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/infdis\/jir711","article-title":"A vero cell-derived whole-virus H5N1 vaccine effectively induces neuraminidase-inhibiting antibodies","volume":"205","author":"Fritz","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.amepre.2015.09.012_bib45","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1371\/journal.pmed.0040059","article-title":"Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans","volume":"4","author":"Sandbulte","year":"2007","journal-title":"PLOS Med"},{"key":"10.1016\/j.amepre.2015.09.012_bib46","article-title":"Phase 2 clinical evaluation of an influenza A virus recombinant N2 neuraminidase. In: options for the control of influenza IV","author":"Schiff","year":"2000","journal-title":"Crete"},{"key":"10.1016\/j.amepre.2015.09.012_bib47","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1128\/JVI.64.3.1375-1377.1990","article-title":"Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice","volume":"64","author":"Treanor","year":"1990","journal-title":"J Virol"},{"key":"10.1016\/j.amepre.2015.09.012_bib48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1099\/0022-1317-74-1-143","article-title":"Antibody response to the M2 protein of influenza A virus expressed in insect cells","volume":"74","author":"Black","year":"1993","journal-title":"J Gen Virol"},{"key":"10.1016\/j.amepre.2015.09.012_bib49","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/infdis\/jit811","article-title":"Serum antibody response to matrix 2 protein following natural infection with 2009 pandemic influenza A (H1N1) virus in humans","volume":"209","author":"Zhong","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.amepre.2015.09.012_bib50","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.4049\/jimmunol.172.9.5598","article-title":"vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity","volume":"172","author":"Jegerlehner","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.amepre.2015.09.012_bib51","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/eji.201041225","article-title":"Universal vaccine against influenza virus: linking TLR signaling to anti-viral protection","volume":"42","author":"Schmitz","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.amepre.2015.09.012_bib52","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.vaccine.2007.10.062","article-title":"Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin","volume":"26","author":"Huleatt","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.amepre.2015.09.012_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2014.01.002","article-title":"Microneedle delivery of an M2e-TLR5 ligand fusion protein to skin confers broadly cross-protective influenza immunity","volume":"178","author":"Wang","year":"2014","journal-title":"J Controlled Release"},{"key":"10.1016\/j.amepre.2015.09.012_bib54","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.vaccine.2012.11.072","article-title":"Tandem repeats of the extracellular domain of Matrix 2 influenza protein exposed in Brucella lumazine synthase decameric carrier molecule induce protection in mice","volume":"31","author":"Alvarez","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.amepre.2015.09.012_bib55","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.amepre.2015.09.012_bib56","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.antiviral.2013.06.010","article-title":"Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection","volume":"99","author":"Kim","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.amepre.2015.09.012_bib57","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1016\/j.vaccine.2014.06.040","article-title":"AS04-adjuvanted virus-like particles containing multiple M2 extracellular domains of influenza virus confer improved protection","volume":"32","author":"Lee","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.amepre.2015.09.012_bib58","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.nano.2013.08.005","article-title":"Nanoclusters self-assembled from conformation-stabilized influenza M2e as broadly cross-protective influenza vaccines","volume":"10","author":"Wang","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.amepre.2015.09.012_bib59","doi-asserted-by":"crossref","first-page":"6280","DOI":"10.1016\/j.vaccine.2009.07.007","article-title":"M2e-based universal influenza A vaccine","volume":"27","author":"Fiers","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.amepre.2015.09.012_bib60","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/infdis\/jiu539","article-title":"Efficacy and safety of treatment with an anti-M2e monoclonal antibody in experimental human influenza","volume":"211","author":"Ramos","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.amepre.2015.09.012_bib61","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1128\/JCM.25.3.559-562.1987","article-title":"Analsyis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum","volume":"25","author":"Wagner","year":"1987","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.amepre.2015.09.012_bib62","first-page":"107","article-title":"The systemic and mucosal immune response of humans to influenza","volume":"146","author":"Murphy","year":"1989","journal-title":"Virus Curr Top Microbiol Immunol"},{"key":"10.1016\/j.amepre.2015.09.012_bib63","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.4049\/jimmunol.146.6.1972","article-title":"Passive transfer of local immunity to influenza virus by IgA antibody","volume":"146","author":"Renegar","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.amepre.2015.09.012_bib64","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0022-3476(00)70097-7","article-title":"Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A\/Sydney) not contained in the vaccine","volume":"136","author":"Belshe","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.amepre.2015.09.012_bib65","doi-asserted-by":"crossref","first-page":"6901","DOI":"10.1073\/pnas.89.15.6901","article-title":"Intracellular neutralization of virus by immunoglobulin A antibodies","volume":"89","author":"Mazanec","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.amepre.2015.09.012_bib66","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1128\/JVI.75.11.5141-5150.2001","article-title":"Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection","volume":"75","author":"Tumpey","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.amepre.2015.09.012_bib67","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM198307073090103","article-title":"Cytotoxic T-cell immunity to influenza","volume":"309","author":"McMichael","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amepre.2015.09.012_bib68","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1128\/CVI.00397-07","article-title":"Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children","volume":"15","author":"Forrest","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.amepre.2015.09.012_bib69","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nm.2612","article-title":"Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans","volume":"18","author":"Wilkinson","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.amepre.2015.09.012_bib70","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/nm.3350","article-title":"Cellular immune correlates of protection against symptomatic pandemic influenza","volume":"19","author":"Sridhar","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.amepre.2015.09.012_bib71","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.4161\/hv.25598","article-title":"Universal H1N1 influenza vaccine development: identification of consensus class II hemagglutinin and neuraminidase epitopes derived from strains circulating between 1980 and 2011","volume":"9","author":"Moise","year":"2013","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.amepre.2015.09.012_bib72","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.humimm.2010.02.014","article-title":"Identification of broad binding class I HLA supertype epitopes to provide universal coverage of influenza A virus","volume":"71","author":"Alexander","year":"2010","journal-title":"Hum Immunol"},{"key":"10.1016\/j.amepre.2015.09.012_bib73","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.vaccine.2009.10.103","article-title":"Universal influenza DNA vaccine encoding conserved CD4+ T cell epitopes protects against lethal viral challenge in HLA-DR transgenic mice","volume":"28","author":"Alexander","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.amepre.2015.09.012_bib74","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1016\/j.vaccine.2014.08.031","article-title":"Priming by a novel universal influenza vaccine (Multimeric-001)-a gateway for improving immune response in the elderly population","volume":"32","author":"Atsmon","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.amepre.2015.09.012_bib75","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1002\/eji.201344005","article-title":"Vaccinia-based influenza vaccine overcomes previously induced immunodominance hierarchy for heterosubtypic protection","volume":"44","author":"Kwon","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.amepre.2015.09.012_bib76","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.4049\/jimmunol.1300954","article-title":"Protective CD8 T cell-mediated immunity against influenza A virus infection following influenza virus-like particle vaccination","volume":"191","author":"Hemann","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.amepre.2015.09.012_bib77","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/icb.2011.70","article-title":"Return of inactivated whole-virus vaccine for superior efficacy","volume":"90","author":"Furuya","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.amepre.2015.09.012_bib78","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1086\/592172","article-title":"Safety and immunogenicity of an inactivated influenza A\/H5N1 vaccine given without or with aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial","volume":"198","author":"Keitel","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.amepre.2015.09.012_bib79","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1086\/508174","article-title":"Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A\/H9N2 vaccine preparations","volume":"43","author":"Atmar","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amepre.2015.09.012_bib80","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0140-6736(07)61297-5","article-title":"Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial","volume":"370","author":"Leroux-Roels","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.amepre.2015.09.012_bib81","doi-asserted-by":"crossref","first-page":"7962","DOI":"10.1073\/pnas.0903181106","article-title":"Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine","volume":"106","author":"Galli","year":"2009","journal-title":"Proc Nat Acad Sci U S A"},{"key":"10.1016\/j.amepre.2015.09.012_bib82","doi-asserted-by":"crossref","first-page":"85ra48","DOI":"10.1126\/scitranslmed.3002336","article-title":"MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines","volume":"3","author":"Khurana","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.amepre.2015.09.012_bib83","doi-asserted-by":"crossref","first-page":"e33536","DOI":"10.1371\/journal.pone.0033536","article-title":"AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland","volume":"7","author":"Nohynek","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.amepre.2015.09.012_bib84","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1099\/0022-1317-83-8-1851","article-title":"Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza a virus","volume":"83","author":"Heinen","year":"2002","journal-title":"J Gen Virol"},{"key":"10.1016\/j.amepre.2015.09.012_bib85","doi-asserted-by":"crossref","first-page":"200ra114","DOI":"10.1126\/scitranslmed.3006366","article-title":"Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease","volume":"5","author":"Khurana","year":"2013","journal-title":"Sci Transl Med"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379715005516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379715005516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T22:06:36Z","timestamp":1692137196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379715005516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":85,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0749379715005516"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2015.09.012","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospects for Broadly Protective Influenza Vaccines","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2015.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}